Efficacy and safety of cinnarizine in the prophylaxis of migraine headaches in children: An open, randomized comparative trial with propranolol

Acta Neurologica Belgica

Volumn 112, Issue 1, 2012, Pages 51-55

  Togha, Mansoureh ^a   Malamiri, Reza Azizi ^b,c   Rashidi Ranjbar, Neda ^b   Asa, Solmaz ^b   Mahvelati, Farhad ^d   Ashrafi, Mahmoud Reza ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Children; Cinnarizine; Migraine; Prophylaxis; Propranolol

Indexed keywords

CINNARIZINE; PROPRANOLOL;

ADOLESCENT; ARTICLE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DAYTIME SEDATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; TREATMENT RESPONSE;

EID: 84865476400     PISSN: 03009009     EISSN: 22402993     Source Type: Journal    
DOI: 10.1007/s13760-012-0011-7     Document Type: Article

References (26)

1. Lewis D, Winner P, Saper J, Ness S, Polverejan E et al (2009) Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 123:924-934
2. Lewis DW (2009) Pediatric migraine. Neurol Clin 27:481-501
3. Pakalnis A (2006) Pediatric migraine: new diagnostic strategies and treatment options. Expert Rev Neurother 6:291-296
4. Pakalnis A (2002) Current therapies for prophylaxis of pediatric migraine. Expert Rev Neurother 2:555-559
5. Damen L, Bruijn J, Verhagen AP, Berger MY, Passchier J et al (2006) Prophylactic treatment of migraine in children. Part 2. A systematic review of pharmacological trials. Cephalalgia 26: 497-505
6. Caruso JM, Brown WD, Exil G, Gascon GG (2000) The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 40:672-676
7. Pakalnis A, Greenberg G, Drake ME Jr, Paolichi J (2001) Pediatric migraine prophylaxis with divalproex. J Child Neurol 16: 731-734
8. Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC et al (2005) Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 45: 1304-1312
9. Lakshmi CV, Singhi P, Malhi P, Ray M (2007) Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol 22:829-835
10. Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F (2005) Sodium valproate versus propranolol in paediatric migraine prophylaxis. Eur J Paediatr Neurol 9:333-338
11. Rao BS, Das DG, Taraknath VR, Sarma Y (2000) A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Neurol India 48:223-226
12. Cruz MJ, Valencia I, Legido A, Kothare SV, Khurana DS et al (2009) Efficacy and tolerability of topiramate in pediatric migraine. Pediatr Neurol 41:167-170
13. Sorge F, De Simone R, Marano E, Nolano M, Orefice G et al (1988) Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 8:1-6
14. Sorge F, Marano E (1985) Flunarizine v. placebo in childhood migraine. A double-blind study. Cephalalgia 5(Suppl 2):145-148
15. Battistella PA, Ruffilli R, Moro R, Fabiani M, Bertoli S et al (1990) A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache 30:264-268
16. Rossi P, Fiermonte G, Pierelli F (2003) Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial. Funct Neurol 18:155-159
17. Togha M, Ashrafian H, Tajik P (2006) Open-label trial of cinnarizine in migraine prophylaxis. Headache 46:498-502
18. Petkov GV, Fusi F, Saponara S, Gagov HS, Sgaragli GP et al (2001) Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery. Acta Physiol Scand 173:257-265
19. Miller GS (2004) Efficacy and safety of levetiracetam in pediatric migraine. Headache 44:238-243
20. Dooley JM, Gordon KE (2006) The role of pharmacotherapy in pediatric migraine. Headache 46:195-196
21. Olesen J (2004) Headache Classification Sub-Committee of the International Headache Society. The International Classification of Headache Disorder, 2nd edn. Cephalagia 24(1):1-160
22. Turner D, Lurie Y, Finkelstein Y, Schmid T, Gopher A et al (2006) Pediatric cinnarizine overdose and toxicokinetics. Pediatrics 117:e1067-e1069
23. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M et al (2004) Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 63:2215-2224
24. Togha M, Rahmat Jirde M, Nilavari K, Ashrafian H, Razeghi S et al (2008) Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. J Headache Pain 9:77-82
25. Arab SF, Duwel P, Jungling E, Westhofen M, Luckhoff A (2004) Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizine. Naunyn Schmiedebergs Arch Pharmacol 369:570-575
26. Pianese CP, Hidalgo LO, Gonzalez RH, Madrid CE, Ponce JE et al (2002) New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12 week, multinational, double-blind study. Otol Neurotol 23: 357-363